Wednesday, May 13, 2009 9:35:01 AM
http://www.marketwatch.com/story/bioforce-nanosciences-voluntarily-files-form
AMES, IA, Apr 14, 2009 (MARKET WIRE via COMTEX) -- BioForce Nanosciences Holdings, Inc. (BFNH 0.07, +0.01, +16.47%) , a producer of products and
solutions for academic and commercial users based upon its ultra-micro to nano scale fluid deposition platform, filed paperwork today with the Securities and Exchange Commission (SEC) to terminate the Company's registration under the Securities Exchange Act of 1934, as amended. As a result, the Company's obligation to file periodic and current reports with the SEC, including Forms 10-K, 10-Q and 8-K, has been suspended.
Kerry Frey, President and Chief Executive Officer of BioForce, said, "We engaged in a thorough analysis of the benefits and costs associated with remaining a small reporting company. Factors considered included the onerous costs of compliance required by the Sarbanes-Oxley Act of 2002, the ongoing burden associated with the preparation and filing of periodic and current reports with the SEC, and the substantial diversion of management's time and efforts from the tasks required to grow the Company's business. Our conclusion was that in this environment we could no longer justify the estimated $200,000 of annual costs of SEC reporting and Sarbanes-Oxley compliance, and that those funds are better spent on value creating activities such as sales, marketing and product development."
Greg Brown, Executive Vice President and Chief Financial Officer of BioForce, said, "BioForce is not going private or 'going dark.' While no longer required by the SEC after deregistering, we plan to continue to provide quarterly and annual updates, and other information regarding the Company's performance to its shareholders via the Pink Sheets' OTC News and Disclosure Service as well as through our e-mail database and website. In addition, the Company anticipates that trading will continue in the Company's common stock on the Pink Sheets under the same symbol of 'BFNH.'"
For further information about this release please contact Greg Brown, Chief Financial Officer of BioForce at (515) 233-8333 ext. 118, or Rich Kaiser, Investor Relations at (800) 631-8127.
About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences produces products and solutions for academic and commercial users based upon its ultra-micro to nano scale fluid deposition platform. BioForce's flagship product, the Nano eNabler(TM) molecular printer, gives the Company and its customers a platform for development and discovery by printing tiny domains of biological materials on surfaces with nanometer spatial precision. BioForce technology is being used in areas such as biosensor functionalization; patterning and cell adhesion; and the printing of proteins to direct stem cell differentiation. For more information, visit www.bioforcenano.com or call 515-233-8333.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in BioForce Nanosciences' most recent filings with the Securities and Exchange Commission. BioForce Nanosciences' actual results could differ materially from such forward-looking statements. BioForce assumes no duty to update these statements at any future date.
Contacts:
Company Contact
Gregory D. Brown
Chief Financial Officer
515-233-8333 ext# 118
Email Contact
Investor Relations
Yes International
Rich Kaiser
800-631-8127
SOURCE: BioForce Nanosciences Holdings, Inc.
http://www2.marketwire.com/mw/emailprcntct?id=7CF6E1EDEA2EA0E6
Recent BFNH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 03:38:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:23:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2023 01:44:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 08:16:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 08:07:53 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM